Identification of novel HIV 1--protease inhibitors: application of ligand and structure based pharmacophore mapping and virtual screening.
A combined ligand and structure-based drug design approach provides a synergistic advantage over either methods performed individually. Present work bestows a good assembly of ligand and structure-based pharmacophore generation concept. Ligand-oriented study was accomplished by employing the HypoGen...
Main Authors: | Divya Yadav, Sarvesh Paliwal, Rakesh Yadav, Mahima Pal, Anubhuti Pandey |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3493599?pdf=render |
Similar Items
-
Chemical Feature-Based Molecular Modeling of Urotensin-II Receptor Antagonists: Generation of Predictive Pharmacophore Model for Early Drug Discovery
by: Anubhuti Pandey, et al.
Published: (2014-01-01) -
Ligand-Based Pharmacophore Modeling and Virtual Screening of RAD9 Inhibitors
by: Nirmal K. Prasad, et al.
Published: (2013-01-01) -
Ligand-based Pharmacophore Modeling, Virtual Screening and Molecular Docking Studies for Discovery of Potential Topoisomerase I Inhibitors
by: Sourav Pal, et al.
Published: (2019-01-01) -
Pharmacophore-Based Virtual Screening of Novel GSTP1-1 Inhibitors
by: Kayhan Bolelli, et al.
Published: (2018-11-01) -
Generation of Ligand-Based Pharmacophore Model and Virtual Screening for Identification of Novel Tubulin Inhibitors with Potent Cellular Anticancer Activity
by: Chiang,Yi-Kun, et al.
Published: (2008)